INFINITY PHARMACEUTICALS INC (INFI) Forecast, Price Target & Analyst Ratings

NASDAQ:INFI • US45665G3039

Current stock price

0.0447 USD
-0.04 (-46.98%)
At close:
0.04 USD
0 (-10.51%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INFINITY PHARMACEUTICALS INC (INFI).

Forecast Snapshot

Consensus Price Target

Price Target
$0.31
+ 584.56% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 13, 2023
Period
Q3 / 2023
EPS Estimate
-$0.12
Revenue Estimate
714K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$0.31
Upside
+ 584.56%
From current price of $0.04 to mean target of $0.31, Based on 6 analyst forecasts
Low
$0.30
Median
$0.31
High
$0.32

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for INFI. The average price target is 0.31 USD. This implies a price increase of 584.56% is expected in the next year compared to the current price of 0.0447.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

INFI Current Analyst RatingINFI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

INFI Historical Analyst RatingsINFI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
INFI was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about INFI.
In the previous month the buy percentage consensus was at a similar level.
INFI was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-02-24Piper SandlerDowngrade Overweight -> Neutral
2022-11-16B. Riley SecuritiesDowngrade Buy -> Neutral
2022-05-23Piper SandlerMaintains Overweight
2021-10-18HC Wainwright & Co.Initiate Buy
2021-08-02JP MorganUpgrade Neutral -> Overweight
2021-07-28Wells FargoUpgrade Equal-Weight -> Overweight
2021-03-18Truist SecuritiesInitiate Buy
2021-03-17Wells FargoMaintains Equal-Weight
2021-02-18Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 13, 2023
Period
Q3 / 2023
EPS Estimate
-$0.12
Revenue Estimate
714K
Revenue Q2Q
0.28%
EPS Q2Q
-2.00%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
100.00%
EPS (1 Month)
0.00%
EPS (3 Months)
4.00%

Next Earnings Summary

INFI is expected to report earnings on 11/13/2023. The consensus EPS estimate for the next earnings is -0.12 USD and the consensus revenue estimate is 714.00K USD.
The next earnings revenue estimate has been revised upward by 100% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
INFI revenue by date.INFI revenue by date.
1.7M
-43.33%		1.858M
9.29%		2.593M
39.56%		2.754M
6.21%		3.57M
29.63%
-100.00%		18.36M56.1M
205.56%		86.7M
54.55%		121.38M
40.00%		154.02M
26.89%
EBITDA
YoY % growth
INFI ebitda by date.INFI ebitda by date.
-38M
16.48%		-44.603M
-17.38%		-44.386M
0.49%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
INFI ebit by date.INFI ebit by date.
-38.5M
15.75%		-45.083M
-17.10%		-44.844M
0.53%		-48.923M
-9.10%		-43.152M
11.80%		-42.84M
0.72%		-23.46M
45.24%		7.14M
130.43%		31.62M
342.86%		57.12M
80.65%		78.54M
37.50%
Operating Margin
INFI operating margin by date.INFI operating margin by date.
-2,264.71%-2,426.43%-1,729.43%-1,776.44%-1,208.73%N/A-127.78%12.73%36.47%47.06%50.99%
EPS
YoY % growth
INFI eps by date.INFI eps by date.
-0.67
18.29%		-0.53
20.90%		-0.50
5.66%		-0.47
6.16%		-0.56
-19.57%		-0.29
49.09%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.12
-2.00%		-0.12
-11.27%		-0.13
-10.50%		-0.13
-8.33%		-0.14
-16.67%		-0.15
-25.00%
Revenue
Q2Q % growth		714K
0.28%		765K
40.88%		816K
11.63%		918K
57.46%		918K
28.57%		1.02M
33.33%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-10.681M
1.83%		-11.426M
-19.79%		-11.406M
0.88%		-12.151M
-20.07%		-12.641M
-18.34%		-13.385M
-17.15%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INFI Yearly Revenue VS EstimatesINFI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 2028 2029 2030 50M 100M 150M
INFI Yearly EPS VS EstimatesINFI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2 -2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.63%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
83.41%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INFINITY PHARMACEUTICALS INC / INFI Forecast FAQ

Can you provide the average price target for INFINITY PHARMACEUTICALS INC stock?

6 analysts have analysed INFI and the average price target is 0.31 USD. This implies a price increase of 584.56% is expected in the next year compared to the current price of 0.0447.

Can you provide the upcoming earnings date for INFINITY PHARMACEUTICALS INC?

INFINITY PHARMACEUTICALS INC (INFI) will report earnings on 2023-11-13, after the market close.

Can you provide the consensus estimates for INFINITY PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of INFINITY PHARMACEUTICALS INC (INFI) is -0.12 USD and the consensus revenue estimate is 714.00K USD.

What is the expected long term growth rate for INFI stock?

The expected long term growth rate for INFINITY PHARMACEUTICALS INC (INFI) is -25.99%.